Table 1.
Genes differentially expressed between HCC and adjacent noamal liver tissues generated by atlasImage software (Version 1.01a)
| Gene | Ratio | Difference | Protein/gene |
| B2f | -42675 | TRAF6 | |
| E2h | 0.171 | -31204 | T-plasminogen activator (T-PA) |
| B3h | 0.444 | -31180 | caspase-8 precursor; MACH; FLICE; (CAP4) (CASP8) |
| D1b | 0.334 | -30676 | byglycan |
| B3i | 0.445 | -30287 | caspase-9 precursor; ICE-LAP6; apoptotic protease MCH-6 |
| B2g | 0.493 | -28449 | TRAF-interacting protein (TRIP) |
| B3g | -27610 | caspase-8 precursor; MCH-5 isoform alpha | |
| E4j | 0.346 | -27534 | CDC42 GTPase-activating protein |
| C7m | 0.336 | -27032 | retinoid X receptor beta (RXR-beta) |
| B1k | 0.438 | -26170 | serine/threonine protein kinase NIK; |
| B3j | 0.486 | -25940 | ICE-like apoptotic protease 4 precursor; caspase-10 |
| B3f | -25206 | caspase-7 precursor; apoptotic protease MCH-3; LICE2 | |
| F2g | 0.428 | -23730 | endothelin ET2 |
| D2a | 0.176 | -22099 | collagen type VIII alpha-1 |
| D7f | 0.47 | -21445 | PLGF1 & 2 precursor (placenta growth factor) |
| C7l | 0.593 | -21145 | retinoic acid receptor gamma |
| A4j | 0.326 | -20847 | extracellular signal-regulated kinase 6 (ERK6) (ERK5) |
| E5b | 0.299 | -20388 | rho GDP-dissociation inhibitor 1 |
| E2f | 0.638 | -20244 | extracellular matrix metalloproteinase inducer emmprin |
| D4j | 0.624 | -20147 | integrin beta7 |
| D2n | 0.646 | -17013 | TENASCIN-R |
| F4l | 0.626 | -16150 | interleukin-6 (IL-6) precursor; BSF-2; interferon beta-2; |
| B5l | 0.633 | -16122 | proto-oncogene rhoA multidrug resistance protein; |
| B7j | 0.639 | -15630 | tyrosine-protein kinase ABL2; tyrosine kinase ARG (ABLL) |
| E7l | 0.721 | -15615 | ephrin type-B receptor 2 precursor; tyrosine-protein eph-3 |
| E1f | 0.318 | -15559 | MMP-9; gelatinase B |
| B2i | 0.245 | -15356 | CD40 receptor associated factor 1 (CRAF1) |
| D5g | 0.569 | -15106 | ezrin (cytovillin 2) |
| E7k | -14688 | ephrin type-B receptor 1 precursor; NET | |
| E1j | -14540 | MMP-13; collagenase-3 | |
| A2f | 0.403 | -14368 | serine/threonine protein kinase PITALRE |
| D5m | 0.38 | -14156 | tumor suppressor DCC colorectal |
| E1e | 0.3 | -13906 | MMP-8; collagenase-2 |
| D2e | 0.295 | -13706 | collagen type XVIII alpha |
| D2m | 0.624 | -12991 | tenascin-C |
| F3j | 0.77 | -12411 | transcription factor ETR103; early growth response protein 1 |
| C2j | 0.648 | -12053 | Rad |
| F5k | 0.68 | -11371 | leukocyte interferon-gamma (IFN-gamma) |
| D5k | 0.643 | -11064 | ninjurin-1 |
| C7k | 0.356 | -11056 | retinoic acid receptor epsilon; retinoic acid receptor beta-2 |
| C1b | 0.392 | -10834 | ataxia telangiectasia (ATM) |
| D4k | 0.799 | -10645 | integrin beta8 |
| D1c | -10630 | CD34 | |
| D3e | 0.798 | -10529 | vitronectin precursor; serum spreading factor; |
| B4c | 0.347 | -10506 | WSL-LR +WSL-S1+WSL-S2+TRAMP (Apo-3) |
| D6c | 0.264 | -10460 | semaphorin E |
| E2n | 0.483 | -9167 | low-density lipoprotein receptor-related protein 1 precursor |
| E5m | 0.351 | -8076 | truncated-cadherin; H-cadherin; heart-cadherin |
| A4n | 0.363 | -7958 | stress-activated protein kinase JNK3; JNK3; |
| A5i | 0.282 | -7204 | E2F-3 |
| E6f | 0.287 | -7197 | neuroendocrine-dlg (NE-dlg); |
| A1e | 0.343 | -7043 | cell division protein kinase 5; kinase PSSALRE |
| E4h | 0.419 | -6025 | rhoHP1 |
| D6h | 0.451 | -4647 | LAR |
| A7n | 0.466 | -4426 | desmin |
| E4e | 2.185 | 4701 | RAS-related C3 botulinum toxin substrate 1 (P21-RAC2) |
| D5f | 1.447 | 10249 | CD9 |
| B7g | 2.841 | 11419 | SKY (DTK) (TYRO3) (RSE) |
| A7d | 2.705 | 13394 | type II cytoskeletal 11 keratin; cytokeratin 1 (K1; CK 1) |
| D6f | 2.772 | 14015 | semaphorin-1 |
| D6e | 3.182 | 15879 | semaphorin V |
| E1b | 3.079 | 15956 | MMP-2; gelatinase A |
| E1m | 2 | 17032 | MMP-16 (MT3-MMP) |